Eagle Pharmaceuticals, Inc. Reports Second Quarter 2017 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Eagle Pharmaceuticals, Inc. Reports Second Quarter 2017 Results

Eagle Pharmaceuticals (EGRX) Tops Q2 EPS by 1c

August 9, 2017 6:51 AM EDT

Eagle Pharmaceuticals (NASDAQ: EGRX) reported Q2 EPS of $0.52, $0.01 better than the analyst estimate of $0.51. Revenue for the quarter came in at $50.1 million versus the consensus estimate of $52.52 million.

For earnings history and earnings-related data on Eagle Pharmaceuticals (EGRX) click here.

... More